QA: Axsome Therapeutics Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001579428_2018_Axsome_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001579428')"}

Graph

Absolute values for 0001579428, Axsome Therapeutics Inc.

  xvar xval
0 AssetsCurrent 35,299,541
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 68,071
3 remainder_Assets 187,952
4 LiabilitiesCurrent 12,175,336
5 LiabilitiesNoncurrent 6,663,005
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,206,691
9 ResearchAndDevelopmentExpense 19,957,616
10 remainder_Expenses 646,000
11 remainder_Revenues 0
12 remainder_NetIncome -1,133,085
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 35,555,564
1 Liabilities 18,838,341
2 Expenses 27,810,307
3 Revenues 0
4 StockholdersEquity 16,717,223
5 NetIncome -28,943,392
6 ComprehensiveNetIncome -28,943,392
7 BaseVar 41,668,648
8 EconomicCapitalRatio -0.00698

Edgar->Model Mapping

Feature Distribution

Change over Time